Zobrazeno 1 - 10
of 20
pro vyhledávání: '"D. L. Fairclough"'
Publikováno v:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 12(8)
Quality of life (QOL) endpoints from a randomized, placebo-controlled trial of anemic cancer patients treated with nonplatinum-containing chemotherapy who received epoetin alfa or placebo were subjected to a sensitivity analysis. Three QOL instrument
Publikováno v:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 8(8)
The objective was to compare health related quality of life (QOL) in hormone receptor negative, node-positive breast cancer patients receiving adjuvant chemotherapy to determine whether a more intensive chemotherapy regimen has an adverse effect upon
Autor:
L B, Wenzel, D L, Fairclough, M J, Brady, D, Cella, K M, Garrett, B C, Kluhsman, L A, Crane, A C, Marcus
Publikováno v:
Cancer. 86(9)
The objective of this study was to compare the quality of life (QOL) of younger (or =50 years) versus older (50 years) women on recent completion of treatment of breast carcinoma.Data reported herein were obtained from a baseline assessment of 304 br
Autor:
M, Hall, P A, Sykes, D L, Fairclough, L J, Lucchese, P, Rogers, W, Staruszkiewicz, R C, Bateman
Publikováno v:
Journal of AOAC International. 82(5)
This study describes the production of a solid-phase assay (test strip/dipstick test) for putrescine and cadaverine in tuna based on the coupling of an amine oxidase to a peroxidase/dye system. The assay was linear to 75 microM in phosphate buffer, a
Publikováno v:
Statistics in medicine. 17(5-7)
Incorporation of quality of life (QOL) investigation into Eastern Cooperative Oncology Group (ECOG) multi-centre clinical trials has led to innovative strategies for protocol design and high quality data collection. A scientific advisory committee re
Publikováno v:
Statistics in medicine. 17(5-7)
Assessment of health related quality of life has become an important endpoint in many cancer clinical trials. Because the participants of these trials often experience disease and treatment related morbidity and mortality, non-random missing assessme
Publikováno v:
Statistics in medicine. 17(5-7)
We summarize issues that arise when considering quality of life (QOL) data in cancer clinical trials, especially those related to missing data. We describe different types of missing data mechanisms, and discuss ways of assessing and testing missing
Autor:
D L, Fairclough
Publikováno v:
Statistics in medicine. 16(11)
Assessment of health related quality of life (QOL) has become an important endpoint in many clinical trials of cancer therapy. Most of these studies entail multiple QOL scales that are assessed repeatedly over time. As a result, the problem of multip
Autor:
D L, Fairclough, D F, Cella
Publikováno v:
Journal of the National Cancer Institute. Monographs. (20)
Autor:
B I, Razzouk, R L, Heideman, H S, Friedman, J J, Jenkins, L E, Kun, D L, Fairclough, M E, Horowitz
Publikováno v:
Cancer. 75(11)
Chemotherapy may be used to delay the need for cranial irradiation in infants and young children with malignant central nervous system (CNS) tumors. The polyfunctional alkylator thiotepa (TT) possesses significant in vitro and in vivo activity in man